-
Thursday, March 30, 2023
The results of a multi-institutional clinical trial led by Keck Medicine of USC show that surgically removing abdominal lymph nodes impacted by seminoma can treat the illness as effectively as chemotherapy and radiation, which would mean fewer long-term side effects. The findings were published in the Journal of Clinical Oncology.... Read More »
-
Wednesday, March 29, 2023
Bold ideas, smart investments and strong compassion helped USC navigate the COVID-19 pandemic, and those assets are key to future growth in health sciences, USC President Carol L. Folt said Wednesday in the second of two annual State of the University speeches. “We have faced down challenges that come only... Read More »
-
Tuesday, March 28, 2023
Keck Medicine of USC has been recognized as one of 150 top places to work in health care by Becker’s Healthcare, which publishes Becker’s Hospital Review. The award is given annually to hospitals and health systems that invest in employees by providing comprehensive benefits packages, professional development opportunities, inclusive work... Read More »
-
Tuesday, March 28, 2023
USC Verdugo Hills Hospital welcomed 73 students from local high schools for its annual Healthcare Day of Discovery, which welcomes a diverse array of students considering careers in health care. “They get a wonderful hands-on experience and get to talk with a wide range of people, explore the hospital and... Read More »
-
Monday, March 27, 2023
Felipe Osorno has been named chief post-acute care officer and chief of staff for Keck Medicine of USC. Osorno brings 15 years of health care leadership experience to the role, which he will assume immediately, Keck Medicine CEO Rod Hanners announced on March 24. Osorno will provide executive oversight of... Read More »
-
Wednesday, March 22, 2023
Researchers at the Keck School of Medicine of USC have found a drug with the potential for curbing the painful hyperinflammation caused by osteoarthritis. The findings, published in Science Translational Medicine, indicate that a drug compound, R805/CX-011, may modulate an important cell receptor in the body’s immune system, GP130, that... Read More »
-
Monday, March 20, 2023
In honor of Women’s History Month, ophthalmologists Jesse Berry, MD, and Linda Lam, MD, MBA, of the USC Roski Eye Institute share their experiences as women in their field, including obstacles they faced on their way to becoming physicians. Today both specialists are highly accomplished — Berry serves as the... Read More »
-
Monday, March 20, 2023
At 9 a.m. on the Health Sciences Campus, the MD students of the class of 2023 tore open their assigned, sealed envelopes in sync with students across the nation. It was Match Day, an annual, nationwide event taking place on March 17, where soon-to-be MDs learn which of their top... Read More »
-
Thursday, March 16, 2023
As California ends its COVID-19 State of Emergency, updating statewide guidelines for health care settings, Keck Medical Center of USC has announced important policy adjustments for testing and masking. The changes will go into effect on March 20, 2023 and will also apply to all Keck Medicine of USC ambulatory... Read More »
-
Thursday, March 16, 2023
Keck Medicine of USC has launched a Phase 2 clinical trial investigating the effectiveness of a new outpatient, nonsurgical endoscopic procedure in stabilizing blood glucose levels for patients. The procedure is designed for patients before they require insulin. It targets the duodenum (the first part of the small intestine), which works with... Read More »
-
Tuesday, March 14, 2023
A study from USC Stem Cell has revealed how a specific gene contributes to the development of bones, tendons and glands in the jaw. All three develop from the same type of stem cell — known as neural crest-derived cells — which ideally develop into the right types of material... Read More »